Weill Institute for Cell and Molecular Biology awards 2025 Fleming Fellowship

For research excellence into how living structures recover and preserve order in morphology amid constant disruption, postdoctoral scientist Lanxi Hu has been awarded the Weill Institute for Cell and Molecular Biology’s 2025 Sam and Nancy Fleming Research Fellowship.   

Around Cornell

REEgen wins $150,000 in FuzeHub Commercialization Competition

REEgen, a Cornell spinout focused on rare earth element (REE) recovery, won the $150,000 grand prize at the 2025 FuzeHub Commercialization Competition, held at the New York State Innovation Summit on Oct. 29-30.

Around Cornell

Molecular switch could cause painful side effect of chemo

Chemotherapy activates a stress sensor in immune cells, which may help explain why many cancer patients experience debilitating pain as a side effect, according to Weill Cornell Medicine and Wake Forest University researchers.

Teens prepared for puberty report fewer mental health issues

New study suggests that teens who understand the changes caused by puberty will be more confident in handling those changes, a concept called pubertal self-efficacy.

New tech can unlock mysteries of genome’s hidden half

Cornell researchers have found that a new DNA sequencing technology can be used to study how transposons move within and bind to the genome.

Reviving exhausted immune cells boosts tumor elimination

A new study shows that tumors not only evade the immune system but can actively reprogram immune cells to stop fighting.

Cornell ash trees aim to beat back borer insects

Cornell Botanic Gardens is collaborating with conservation partners to propagate trees resistant to emerald ash borers.   

Five questions for: James Grimmelmann

An August article by Grimmelman, co-authored with A. Feder Cooper, Ph.D. ’24, was cited in a landmark European court ruling against OpenAI on Nov. 11. 

Hypertension affects the brain much earlier than expected

Hypertension impairs blood vessels, neurons and white matter in the brain well before the condition causes a measurable rise in blood pressure, according to a new preclinical study from Weill Cornell Medicine investigators.